These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


424 related items for PubMed ID: 11960382

  • 1. The N-myc and c-myc downstream pathways include the chromosome 17q genes nm23-H1 and nm23-H2.
    Godfried MB, Veenstra M, v Sluis P, Boon K, v Asperen R, Hermus MC, v Schaik BD, Voûte TP, Schwab M, Versteeg R, Caron HN.
    Oncogene; 2002 Mar 27; 21(13):2097-101. PubMed ID: 11960382
    [Abstract] [Full Text] [Related]

  • 2. Evidence for nm23 RNA overexpression, DNA amplification and mutation in aggressive childhood neuroblastomas.
    Leone A, Seeger RC, Hong CM, Hu YY, Arboleda MJ, Brodeur GM, Stram D, Slamon DJ, Steeg PS.
    Oncogene; 1993 Apr 27; 8(4):855-65. PubMed ID: 8384356
    [Abstract] [Full Text] [Related]

  • 3. Read-through transcript from NM23-H1 into the neighboring NM23-H2 gene encodes a novel protein, NM23-LV.
    Valentijn LJ, Koster J, Versteeg R.
    Genomics; 2006 Apr 27; 87(4):483-9. PubMed ID: 16442775
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of a new differentiation pathway in neuroblastoma by copy number defects of N-myc, Cdc42, and nm23 genes.
    Valentijn LJ, Koppen A, van Asperen R, Root HA, Haneveld F, Versteeg R.
    Cancer Res; 2005 Apr 15; 65(8):3136-45. PubMed ID: 15833843
    [Abstract] [Full Text] [Related]

  • 5. Independent and differential expression of two isotypes of human Nm23: analysis of the promoter regions of the nm23-H1 and H2 genes.
    Okada K, Urano T, Baba H, Furukawa K, Furukawa K, Shiku H.
    Oncogene; 1996 Nov 07; 13(9):1937-43. PubMed ID: 8934540
    [Abstract] [Full Text] [Related]

  • 6. Neuroblastoma specific effects of DR-nm23 and its mutant forms on differentiation and apoptosis.
    Negroni A, Venturelli D, Tanno B, Amendola R, Ransac S, Cesi V, Calabretta B, Raschellà G.
    Cell Death Differ; 2000 Sep 07; 7(9):843-50. PubMed ID: 11042679
    [Abstract] [Full Text] [Related]

  • 7. MYCN amplification and 17q in neuroblastoma: evidence for structural association.
    O'Neill S, Ekstrom L, Lastowska M, Roberts P, Brodeur GM, Kees UR, Schwab M, Bown N.
    Genes Chromosomes Cancer; 2001 Jan 07; 30(1):87-90. PubMed ID: 11107180
    [Abstract] [Full Text] [Related]

  • 8. Effects of all-trans retinoic acid and epidermal growth factor on the expression of nm23-H1 in human hepatocarcinoma cells.
    Liu F, Qi HL, Chen HL.
    J Cancer Res Clin Oncol; 2000 Feb 07; 126(2):85-90. PubMed ID: 10664247
    [Abstract] [Full Text] [Related]

  • 9. Identification of a second human nm23 gene, nm23-H2.
    Stahl JA, Leone A, Rosengard AM, Porter L, King CR, Steeg PS.
    Cancer Res; 1991 Jan 01; 51(1):445-9. PubMed ID: 1988104
    [Abstract] [Full Text] [Related]

  • 10. Expression of nm23 in cell lines derived from patients with metastatic renal cell carcinoma.
    Walther MM, Anglard P, Gnarra J, Pozzatti R, Venzon D, de la Rosa A, MacDonald NJ, Steeg PS, Linehan WM.
    J Urol; 1995 Jul 01; 154(1):278-82. PubMed ID: 7776445
    [Abstract] [Full Text] [Related]

  • 11. Characterization of the human nm23-H2 promoter region and localization of the microsatellite D17S396.
    Seifert M, Seib T, Engel M, Dooley S, Welter C.
    Biochem Biophys Res Commun; 1995 Oct 24; 215(3):910-4. PubMed ID: 7488060
    [Abstract] [Full Text] [Related]

  • 12. NM23-H1 and NM23-H2 messenger RNA abundance in human hepatocellular carcinoma.
    Iizuka N, Oka M, Noma T, Nakazawa A, Hirose K, Suzuki T.
    Cancer Res; 1995 Feb 01; 55(3):652-7. PubMed ID: 7530600
    [Abstract] [Full Text] [Related]

  • 13. [Amplification, clone and identification of the specific fragments of tumor metastasis-suppressor gene nm23-H1 and nm23-H2].
    Li C, Lu Y, Wang R.
    Hua Xi Kou Qiang Yi Xue Za Zhi; 1997 Nov 01; 15(4):322-4. PubMed ID: 11479979
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma.
    Bown N, Cotterill S, Lastowska M, O'Neill S, Pearson AD, Plantaz D, Meddeb M, Danglot G, Brinkschmidt C, Christiansen H, Laureys G, Speleman F, Nicholson J, Bernheim A, Betts DR, Vandesompele J, Van Roy N.
    N Engl J Med; 1999 Jun 24; 340(25):1954-61. PubMed ID: 10379019
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. P53 is a regulator of the metastasis suppressor gene Nm23-H1.
    Chen SL, Wu YS, Shieh HY, Yen CC, Shen JJ, Lin KH.
    Mol Carcinog; 2003 Apr 24; 36(4):204-14. PubMed ID: 12669312
    [Abstract] [Full Text] [Related]

  • 18. NM23-H1 and NM23-H2 gene expression in human renal tumors.
    Theisinger B, Engel M, Seifert M, Seitz G, Welter C.
    Anticancer Res; 1998 Apr 24; 18(2A):1185-9. PubMed ID: 9615786
    [Abstract] [Full Text] [Related]

  • 19. Gene structure, promoter activity, and chromosomal location of the DR-nm23 gene, a related member of the nm23 gene family.
    Martinez R, Venturelli D, Perrotti D, Veronese ML, Kastury K, Druck T, Huebner K, Calabretta B.
    Cancer Res; 1997 Mar 15; 57(6):1180-7. PubMed ID: 9067290
    [Abstract] [Full Text] [Related]

  • 20. Alteration of nm23 gene expression during the induced differentiation of human leukemia cell lines.
    Yamashiro S, Urano T, Shiku H, Furukawa K.
    Oncogene; 1994 Sep 15; 9(9):2461-8. PubMed ID: 8058309
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 22.